[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @paulpetertak Dr. Paul Peter Tak Dr. Paul Peter Tak posts on X about $cadl, tak, $130m, approved the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1712158382/interactions)  - X Week XXXXX -XX% - X Month XXXXX +17% - X Months XXXXXX -XX% - X Year XXXXXXX +441% ### Mentions: X [#](/creator/twitter::1712158382/posts_active)  ### Followers: XXXXX [#](/creator/twitter::1712158382/followers)  - X Week XXXXX +1.30% - X Month XXXXX +2.60% - X Months XXXXX +16% - X Year XXXXX +35% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1712158382/influencer_rank)  ### Social Influence [#](/creator/twitter::1712158382/influence) --- **Social category influence** [finance](/list/finance) **Social topic influence** [$cadl](/topic/$cadl) #7, [tak](/topic/tak) #1428, [$130m](/topic/$130m), [approved](/topic/approved), [market cap](/topic/market-cap), [small cap](/topic/small-cap), [over the](/topic/over-the), [regulatory](/topic/regulatory) ### Top Social Posts [#](/creator/twitter::1712158382/posts) --- Top posts by engagements in the last XX hours "Another successful example of the effects of viral immunotherapies in solid tumors the new frontier in immunotherapy for cancer. Congratulations CG Oncology #viral #immunotherapy #solid #tumor #cancer @cgoncology @CandelTx" [X Link](https://x.com/paulpetertak/status/1786430350383575271) [@paulpetertak](/creator/x/paulpetertak) 2024-05-03T16:19Z 1825 followers, XXX engagements "$CADL About our prioritization and financing strategy. Candel Therapeutics secures $130M loan facility to advance clinical pipeline @CandelTx #CADL" [X Link](https://x.com/paulpetertak/status/1978191588628025370) [@paulpetertak](/creator/x/paulpetertak) 2025-10-14T20:10Z 1825 followers, 1843 engagements "In all fairness to IBRX ANKTIVA is currently approved by the FDA for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ. Their share price had its ups and downs before it became more reasonable. Generally market cap of small cap biotech before approval of a medicine is not a great predictor of ultimate value creation. If we look at guidance from nearly all analysts $CADL target share price is nearly 4x the current share price supported by analysis and KOL feedback. Lets see where we are if CAN-2409 is approved for localized" [X Link](https://x.com/paulpetertak/status/1978720592351162528) [@paulpetertak](/creator/x/paulpetertak) 2025-10-16T07:12Z 1826 followers, XXX engagements "Im not an analyst. but Im happy for PRAX that after a lot of volatility over the years theyre back from the dead - and rightly so. Staying calm and focused on the right science will ultimately be rewarded and it may happen swiftly and unexpectedly. Im not sure CADL doesnt get love from WS. Our institutional investor base is high-profile stable and supportive. Nearly all WS analysts indicate a target share price 4x the current share price. We also stay calm and focused on the right science and operational excellence and are confident about the path forward" [X Link](https://x.com/paulpetertak/status/1978958480875630763) [@paulpetertak](/creator/x/paulpetertak) 2025-10-16T22:57Z 1825 followers, XXX engagements "@Biotech2k1 Thank you for doing research on $CADL" [X Link](https://x.com/paulpetertak/status/1978359539494719701) [@paulpetertak](/creator/x/paulpetertak) 2025-10-15T07:17Z 1825 followers, XXX engagements "@papa_spiegs @Gmania99 Thank you. Our decorated Chief Regulatory Officer Sue Stewart will make the right decision for us" [X Link](https://x.com/paulpetertak/status/1979168348316287110) [@paulpetertak](/creator/x/paulpetertak) 2025-10-17T12:51Z 1825 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@paulpetertak Dr. Paul Peter Tak
Dr. Paul Peter Tak posts on X about $cadl, tak, $130m, approved the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXX +17%
- X Months XXXXXX -XX%
- X Year XXXXXXX +441%
Mentions: X #
Followers: XXXXX #
- X Week XXXXX +1.30%
- X Month XXXXX +2.60%
- X Months XXXXX +16%
- X Year XXXXX +35%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance
Social topic influence $cadl #7, tak #1428, $130m, approved, market cap, small cap, over the, regulatory
Top Social Posts #
Top posts by engagements in the last XX hours
"Another successful example of the effects of viral immunotherapies in solid tumors the new frontier in immunotherapy for cancer. Congratulations CG Oncology #viral #immunotherapy #solid #tumor #cancer @cgoncology @CandelTx"
X Link @paulpetertak 2024-05-03T16:19Z 1825 followers, XXX engagements
"$CADL About our prioritization and financing strategy. Candel Therapeutics secures $130M loan facility to advance clinical pipeline @CandelTx #CADL"
X Link @paulpetertak 2025-10-14T20:10Z 1825 followers, 1843 engagements
"In all fairness to IBRX ANKTIVA is currently approved by the FDA for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ. Their share price had its ups and downs before it became more reasonable. Generally market cap of small cap biotech before approval of a medicine is not a great predictor of ultimate value creation. If we look at guidance from nearly all analysts $CADL target share price is nearly 4x the current share price supported by analysis and KOL feedback. Lets see where we are if CAN-2409 is approved for localized"
X Link @paulpetertak 2025-10-16T07:12Z 1826 followers, XXX engagements
"Im not an analyst. but Im happy for PRAX that after a lot of volatility over the years theyre back from the dead - and rightly so. Staying calm and focused on the right science will ultimately be rewarded and it may happen swiftly and unexpectedly. Im not sure CADL doesnt get love from WS. Our institutional investor base is high-profile stable and supportive. Nearly all WS analysts indicate a target share price 4x the current share price. We also stay calm and focused on the right science and operational excellence and are confident about the path forward"
X Link @paulpetertak 2025-10-16T22:57Z 1825 followers, XXX engagements
"@Biotech2k1 Thank you for doing research on $CADL"
X Link @paulpetertak 2025-10-15T07:17Z 1825 followers, XXX engagements
"@papa_spiegs @Gmania99 Thank you. Our decorated Chief Regulatory Officer Sue Stewart will make the right decision for us"
X Link @paulpetertak 2025-10-17T12:51Z 1825 followers, XXX engagements